Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI™ (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease November 9, 2018https://www.prnewswire.com/news-releases/theravance-biopharma-and-mylan-receive-fda-approval-for-yupelri-revefenacin-in-adults-with-chronic-obstructive-pulmonary-disease-300747672.html
